Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines

American Journal of Infectious Diseases

Volumn 3, Issue 3, 2007, Pages 165-168

  Pani, Alessandra ^a   Norfo, Claudia ^a   Abete, Claudia ^a   Mulas, Claudia ^a   Putzolu, Marirosa ^a   Laconi, Sergio ^a   Orrù, Christina Doriana ^a   Cannas, M Dolores ^a   Vascellari, Sarah ^a   La Colla, Paolo ^a   Dessi, Sandra ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cholesterol esters; Inhibitors; Prion protein; Scrapie

Indexed keywords

CHOLESTEROL ESTER; EVEROLIMUS; PIOGLITAZONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BRAIN TISSUE; CELL ISOLATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG ACTIVITY; EVOLUTIONARY ADAPTATION; EX VIVO STUDY; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENOTYPE; LIPID ANALYSIS; LYMPHOCYTE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SCRAPIE; SHEEP; SKIN FIBROBLAST;

EID: 35848930063     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2007.165.168     Document Type: Article

References (13)

1. Cashman N.R., B. Coughey, 2005. Prion diseases- Close to effective therapy? Nat. Rev. Drug Disc., 3: 874-84.
2. Trevitt, CR., J Collinge, 2006. A systemtic review of prion therapeutics in experimental models. Brain, 129 (9): 2241-65
3. Collinge J., J. Whitfield, E. McKintosh, J. Beck, S. Mead, D.J. Thomas, M.P. Alpers, 2006. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet, 367 (9528):2068-74
4. Mead S., S.P. Mahal, J. Beck, T. Campbell, M. Farral, E. Fisher, J. Collinge, 2001. Sporadic- but not variant-Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am. J. Hum. Genet., 69(6): 1225-35
5. Pani A., C. Abete, C. Norfo, C. Mulas, M. Putzolu, S. Laconi, M.D. Cannas, C.D. Orrù, P. La Colla, and S. Dessì, 2007. Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapie resistant or susceptible genotype. Am. J. Infect. Dis. (present issue)
6. Batetta, B., M.F. Mulas, F. Sanna, M. Putzolu, R.R. Bonatesta, A. Casperi-Campani, L. Roncuzzi, D. Baiocchi, S. Dessì, 2003. Role of cholesterol ester pathway in the control of cell cycle in human aortic smooth muscle cells. FASEB J., 17(6):746-8
7. Freeman, D.A., A. Romero, 2003. Effects of troglitazone on intracellular cholesterol distribution and cholesterol-dependent cell functions in MA-10 Leydig tumor cells. Biochem. Pharmacol., 66 (2): 307-13
8. Galantuomo, M., M.F. Mulas, P. Baire, C. Abete, E. Peiretti, S. Dessì, M. Fossarello, 2005. Proliferative Activity and Cholesterol Ester Metabolism in Primary Culture of Human Pterygium Fibroblasts. Invest. Ophthalmol. Vis. Sci., 46 (11): 3982-5
9. Taraboulos A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, S.B. Prusiner, 1995. Cholesterol depletion and modification of COOHterminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell. Biol., 129(1):121-32
10. Gilch, S., C. Kehler, H.M. Schatzl, 2006. The prion protein requires cholesterol for cell surface localization. Mol. Cell Neurosci., 31(2):346-53
11. Bate, C., M. Salmona, L. Diomede, A. Williams, 2004. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J. Biol. Chem., 279(15):14983-90
12. Dessì, S., P. La Colla, A. Pani, 2007. Methods for the diagnosis of proliferative and/or conformational diseases. PCT/IT2007/000110
13. Anchisi, C., S. Dessì, P. La Colla, A. Pani, 2007. Prophylactic and/or therapeutic treatment of proliferative and conformational diseases. PCT/IT2007/000109.